Show simple item record

dc.contributor.authorKolinsky, M
dc.contributor.authorde Bono, JS
dc.date.accessioned2017-08-30T10:22:46Z
dc.date.issued2016-05
dc.identifier.citationEuropean urology, 2016, 69 (5), pp. 841 - 843
dc.identifier.issn0302-2838
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/799
dc.identifier.eissn1873-7560
dc.identifier.doi10.1016/j.eururo.2015.10.052
dc.formatPrint-Electronic
dc.format.extent841 - 843
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectReceptors, Androgen
dc.subjectAndrogen Receptor Antagonists
dc.titleThe Ongoing Challenges of Targeting the Androgen Receptor.
dc.typeJournal Article
dcterms.dateAccepted2015-10-29
rioxxterms.versionofrecord10.1016/j.eururo.2015.10.052
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2016-05
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean urology
pubs.issue5
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.publication-statusPublished
pubs.volume69
pubs.embargo.termsNo embargo
icr.researchteamProstate Cancer Targeted Therapy Groupen_US
dc.contributor.icrauthorDe Bono, Johannen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record